- Home
- Publications
- Publication Search
- Publication Details
Title
Hepatocellular Carcinoma Chemoprevention with Generic Agents
Authors
Keywords
-
Journal
SEMINARS IN LIVER DISEASE
Volume -, Issue -, Pages -
Publisher
Georg Thieme Verlag KG
Online
2022-09-15
DOI
10.1055/a-1942-6693
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis
- (2022) Ian Lockart et al. HEPATOLOGY
- Aspirin Use and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B With or Without Cirrhosis
- (2022) Heejoon Jang et al. HEPATOLOGY
- The clinical management of hepatocellular carcinoma worldwide: A concise review and comparison of current guidelines: 2022 update
- (2022) Ningyuan Wen et al. BioScience Trends
- Fibrosis Stage-specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-acting Antivirals: A Systematic Review and Meta-analysis
- (2022) Nicole J. Kim et al. Clinical Gastroenterology and Hepatology
- Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer
- (2022) Janelle M. Guirguis-Blake et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Aspirin Use and the Risk of Hepatocellular Carcinoma
- (2022) Yikai Wang et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Metformin treatment rescues CD8+ T cell response to immune checkpoint inhibitor therapy in mice with NAFLD
- (2022) Simon Wabitsch et al. JOURNAL OF HEPATOLOGY
- A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma
- (2022) Yikai Wang et al. Canadian Journal of Gastroenterology and Hepatology
- Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
- (2022) Ahmed Omar Kaseb et al. Lancet Gastroenterology & Hepatology
- Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
- (2022) Thomas U Marron et al. Lancet Gastroenterology & Hepatology
- Aspirin use is associated with reduced risk for hepatocellular carcinoma
- (2022) Ronald L. Koretz ANNALS OF INTERNAL MEDICINE
- Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer
- (2022) Daniel Q. Huang et al. Cell Metabolism
- The burden and risks of emerging complications of diabetes mellitus
- (2022) Dunya Tomic et al. Nature Reviews Endocrinology
- Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver disease
- (2022) Naoto Fujiwara et al. Science Translational Medicine
- Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation
- (2022) Emilie Crouchet et al. JCI Insight
- Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus
- (2022) Darren Jun Hao Tan et al. JAMA Network Open
- The Emerging Role of Branched-Chain Amino Acids in Liver Diseases
- (2022) Emily Kwun Kwan Lo et al. Biomedicines
- Neoadjuvant Immunotherapy for Hepatocellular Carcinoma
- (2022) Thomas U Marron et al. Journal of Hepatocellular Carcinoma
- Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
- (2021) Pierre Nahon et al. Journal of Clinical Medicine
- Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults
- (2021) Jiaye Liu et al. Clinical Gastroenterology and Hepatology
- Aspirin in hepatocellular carcinoma
- (2021) Emanuela Ricciotti et al. CANCER RESEARCH
- Cancer Risk in Patients With Biopsy‐Confirmed Nonalcoholic Fatty Liver Disease: A Population‐Based Cohort Study
- (2021) Tracey G. Simon et al. HEPATOLOGY
- State‐Level Hepatocellular Carcinoma Incidence and Association with Obesity and Physical Activity in the United States
- (2021) Yi‐Te Lee et al. HEPATOLOGY
- Cancer statistics for the year 2020: An overview
- (2021) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The Mortality and Overall Survival Trends of Primary Liver Cancer in the United States
- (2021) Yi-Te Lee et al. JNCI-Journal of the National Cancer Institute
- Thymosin alpha-1 therapy improves postoperative survival after curative resection for solitary hepatitis B virus-related hepatocellular carcinoma
- (2021) He Linye et al. MEDICINE
- Systematic review with meta‐analysis: The effects of non‐steroidal anti‐inflammatory drugs and anti‐platelet therapy on the incidence and recurrence of hepatocellular carcinoma
- (2021) Regina Zi Hwei Tan et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Novel deep learning-based transcriptome data analysis for drug-drug interaction prediction with an application in diabetes
- (2021) Qichao Luo et al. BMC BIOINFORMATICS
- Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics
- (2021) Jingjing Jiao et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- S‐Adenosylmethionine Inhibits La Ribonucleoprotein Domain Family Member 1 in Murine Liver and Human Liver Cancer Cells
- (2021) Komal Ramani et al. HEPATOLOGY
- Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis
- (2021) Ashwini Arvind et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery
- (2021) Emilie Crouchet et al. Nature Communications
- Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus
- (2021) Qiaomei Li et al. Clinics and Research in Hepatology and Gastroenterology
- Association of dietary fat intake and hepatocellular carcinoma among US adults
- (2021) Iman Moussa et al. Cancer Medicine
- Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial
- (2021) Hideki Ishikawa et al. Lancet Gastroenterology & Hepatology
- Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development
- (2021) Tongqi Qian et al. GASTROENTEROLOGY
- Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease
- (2021) Jennifer R. Kramer et al. HEPATOLOGY
- Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease
- (2021) Xinrong Zhang et al. HEPATOLOGY
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma
- (2020) Mozhdeh Sojoodi et al. Cancer Prevention Research
- Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
- (2020) Frank Jühling et al. GUT
- Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
- (2020) Antonio Facciorusso et al. Cancers
- Renin-angiotensin system inhibitors and development of hepatocellular carcinoma: A systematic review and meta-analysis
- (2020) Fereshteh Asgharzadeh et al. CURRENT PHARMACEUTICAL DESIGN
- Serum Vitamin D Levels and Risk of Liver Cancer: A Systematic Review and Dose-Response Meta-Analysis of Cohort Studies
- (2020) Yonggui Zhang et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors
- (2020) Andreas A. Schnitzbauer et al. ANNALS OF SURGERY
- Hepatocellular Carcinoma and Statins
- (2020) Ghazal Alipour Talesh et al. BIOCHEMISTRY
- Effects of branched‐chain amino acids on postoperative tumor recurrence in patients undergoing curative resection for hepatocellular carcinoma: A randomized clinical trial
- (2020) Hiroyuki Hachiya et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Drug repurposing for cancer treatments: a well-intentioned, but misguided strategy
- (2020) Audrey A Tran et al. LANCET ONCOLOGY
- Evidence-based medicine and Management of Hepatocellular Carcinoma in Thalassemia
- (2020) Andrea Mancuso BMC GASTROENTEROLOGY
- Do renin-angiotensin system inhibitors reduce risk for hepatocellular carcinoma?: A nationwide nested case-control study
- (2020) Kwang Min Kim et al. Clinics and Research in Hepatology and Gastroenterology
- Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
- (2019) Mohsen Malehmir et al. NATURE MEDICINE
- Chemopreventive Effect of Phytosomal Curcumin on Hepatitis B Virus-Related Hepatocellular Carcinoma in A Transgenic Mouse Model
- (2019) Chiao-Fang Teng et al. Scientific Reports
- Animal Models of Hepatocellular Carcinoma Prevention
- (2019) Ram C. Shankaraiah et al. Cancers
- Xanthophyll β‐Cryptoxanthin Inhibits Highly Refined Carbohydrate Diet–Promoted Hepatocellular Carcinoma Progression in Mice
- (2019) Ji Ye Lim et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
- (2018) Cheng-Maw Ho et al. BMC CANCER
- The development of hepatocellular carcinoma in HCV infected patients treated with DAA: A comprehensive analysis
- (2018) Peng Huang et al. CARCINOGENESIS
- Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial
- (2018) Qian Chen et al. GUT
- Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
- (2018) Naoto Fujiwara et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Cell type-specific pharmacological kinase inhibition for cancer chemoprevention
- (2018) Manjeet Deshmukh et al. Nanomedicine-Nanotechnology Biology and Medicine
- Overcoming the legal and regulatory barriers to drug repurposing
- (2018) Alasdair Breckenridge et al. NATURE REVIEWS DRUG DISCOVERY
- Generic chemoprevention of hepatocellular carcinoma
- (2018) Sai Krishna Athuluri-Divakar et al. Annals of the New York Academy of Sciences
- AACR White Paper: Shaping the Future of Cancer Prevention – A Roadmap for Advancing Science and Public Health
- (2018) Scott M. Lippman et al. Cancer Prevention Research
- Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis
- (2018) Shen Li et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases
- (2017) Benjamin Wooden et al. GASTROENTEROLOGY
- Mice lacking liver-specific β-catenin develop steatohepatitis and fibrosis after iron overload
- (2017) Morgan E. Preziosi et al. JOURNAL OF HEPATOLOGY
- The Essential Medicinal Chemistry of Curcumin
- (2017) Kathryn M. Nelson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial
- (2017) Shunsuke Nojiri et al. NUTRITION
- Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice
- (2017) H Chen et al. ONCOGENE
- Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE 2 -Mediated Suppression of Antitumor Immunity
- (2017) Tze Mun Loo et al. Cancer Discovery
- Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysis
- (2017) Oliver John Kennedy et al. BMJ Open
- Drug-induced adverse events prediction with the LINCS L1000 data
- (2016) Zichen Wang et al. BIOINFORMATICS
- Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis
- (2016) Danielle K. DePeralta et al. CANCER
- Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition
- (2016) Shigeki Nakagawa et al. CANCER CELL
- Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
- (2016) Sahil Mittal et al. Clinical Gastroenterology and Hepatology
- Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer
- (2016) Mei-Hwei Chang et al. GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment
- (2016) Yuko Takami et al. Hepatology International
- Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
- (2016) Edward K. Geissler et al. TRANSPLANTATION
- Activated hepatic stellate cells promote liver cancer by induction of myeloid-derived suppressor cells through cyclooxygenase-2
- (2016) Yaping Xu et al. Oncotarget
- The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: data from the European Prospective Investigation into Cancer and Nutrition
- (2015) Krasimira Aleksandrova et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum -Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP
- (2015) T. R. Morgan et al. Cancer Prevention Research
- A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection – first announcement of the protocol
- (2015) Shuang-Jian Qiu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort
- (2015) Talita Duarte-Salles et al. INTERNATIONAL JOURNAL OF CANCER
- Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients
- (2015) Antonio Facciorusso et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Nonalcoholic fatty liver disease and statins
- (2015) Konstantinos Tziomalos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway
- (2014) Charlotte E Edling et al. CANCER BIOLOGY & THERAPY
- Inverse associations of total and decaffeinated coffee with liver enzyme levels in National Health and Nutrition Examination Survey 1999-2010
- (2014) Qian Xiao et al. HEPATOLOGY
- Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: Multicentre, prospective cohort study
- (2014) Christina Bamia et al. INTERNATIONAL JOURNAL OF CANCER
- Branched-Chain Amino Acids Prevent Hepatocarcinogenesis and Prolong Survival of Patients With Cirrhosis
- (2013) Takumi Kawaguchi et al. Clinical Gastroenterology and Hepatology
- Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
- (2013) Bryan C. Fuchs et al. HEPATOLOGY
- Consumption of n-3 Fatty Acids and Fish Reduces Risk of Hepatocellular Carcinoma
- (2012) Norie Sawada et al. GASTROENTEROLOGY
- Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection
- (2011) Li-Tzong Chen et al. ANNALS OF SURGERY
- Maintenance Therapy With Peginterferon Alfa-2b Does Not Prevent Hepatocellular Carcinoma in Cirrhotic Patients With Chronic Hepatitis C
- (2011) Jordi Bruix et al. GASTROENTEROLOGY
- Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma
- (2009) Hitoshi Yoshiji et al. JOURNAL OF HEPATOLOGY
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers
- (2008) Scott M. Lippman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
- (2008) Adrian M. Di Bisceglie et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now